|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02609 BAYZED HEALTH
Nominal 
6.910 -0.090 (-1.286%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 168,540 | 128,371 | 114,395 |
| Net Cash from / (used in) Investing Activities | 52,166 | (58,606) | (208,680) |
| Net Cash from / (used in) Financing Activities | (168,457) | 47,038 | 53,425 |
| Increase / (Decrease) in Cash & Cash Equivalents | 52,249 | 116,803 | (40,860) |
| Cash & Cash Equivalents at beginning of period | 241,991 | 125,188 | 166,048 |
| Effect of Foreign Exchange Rate Changes | 0 | 0 | 0 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 294,240 | 241,991 | 125,188 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -27,620 |
| %Change | 139.176% |
| EPS / (LPS) | RMB -0.020 |
| NBV Per Share (¥) | RMB 1.154 |